Prior authorization (PA) is utilized by 96% of health plans, and payers show little appetite for relaxing renewal requirements even for stable, lifelong therapies.1 For large health systems and specialty pharmacy hubs, that volume is manageable. The American Medical Association (AMA) reports that 40% of larger physician practices employ staff who work exclusively on prior authorizations.2 But independent pharmacies rarely have that luxury. One pharmacist often manages a full dispensing queue, patient counseling, point-of-care testing, and a specialty PA denial at the same time, with no dedicated coordinator and no payer-specific template on hand.
The Scale of the Burden
The AMA's 2025 Prior Authorization Physician Survey, released in May 2026, found that 95% of physicians say PA delays access to necessary care, and 79% report that patients abandon treatment because of PA friction.3 Physicians complete an average of 39 prior authorizations per week and spend 13 hours on the process, an estimated $34,000 and 700 hours of administrative cost annually per physician.3
That burden does not stay with the prescriber. When a PA is incomplete or missing the right documentation, the rejection lands at the pharmacy counter, not the prescriber's desk. The pharmacist fields the patient's call, coordinates back with the office, and often becomes the de facto translator between payer policy and a clinical team that may not know what that specific payer requires. Sixty percent of practices need at least 3 employees to complete a single PA request, and 35% spend over 35 minutes per request.2 For an independent pharmacy operating on compressed margins, that labor cost is real even when it never appears on a balance sheet.
Specialty Drugs Carry the Heaviest Load
Specialty medications carry the most complex, most payer-specific documentation standards, and they are projected to exceed 60% of pharmacy spend by 2026 despite accounting for fewer than 5% of prescriptions.1 Step therapy requirements, clinical exception pathways, site-of-care edits, and renewal timelines vary by payer, plan, and sometimes individual formulary tier.
A 2025 analysis at a large specialty cancer pharmacy found over 100 PA requests required per week, with 1 in 6 prescriptions ultimately denied and a maximum resolution time of 35 days for specialty drugs.4 That was at a well-resourced center with trained staff. The friction at an independent pharmacy serving a less-resourced population is not likely to be smaller.
Why the Information Gap Is the Real Problem
Utilization management, applied appropriately, serves a legitimate clinical and financial function. The friction is not that PA exists. It is that payers define their criteria internally and communicate them outward imperfectly, so prescribers and pharmacists usually learn what was required only after a rejection tells them what was missing.
A 2026 Surescripts survey found that 51% of prescribers and 47% of pharmacists reported PA denials increasing over the past year.5 As one chief medical officer put it in 2025, the physician writing the prescription often does not know whether a PA is required, what documentation the payer needs, or the current status of the request.6 Independent pharmacies, filling in behind prescriber teams that are already working with incomplete information, face that same gap with fewer resources to close it.
What Closes the Gap
Knowing upfront what a specific payer requires, for a specific drug, for a specific patient's coverage, changes a reactive process into a proactive one. Documentation is complete on the first submission. The right clinical criteria are addressed before the payer asks. Time to therapy shortens, staff time is protected, and the patient gets their medication without a 30-day detour.
That is not a hypothetical fix. It is the specific piece of the PA process that has been missing for independent pharmacies, and the piece that changes outcomes when it is present.
What to Do at Your Counter This Week
- Build a running list of the specific PA documentation requirements for your 5 highest-volume specialty drugs, payer by payer.
- Flag high-friction drug-payer combinations to your highest-volume prescribers before the next fill, not after the next rejection.
- Ask every specialty patient upfront whether their PA has been submitted, and by whom, so gaps surface before day 30.
- Document denial patterns by payer so recurring criteria become institutional memory instead of a surprise every time.
Where Policy Is Headed, and What to Do Before It Arrives
Several states have implemented gold card programs exempting high-approval-rate clinicians from repetitive PA requirements, and the CMS-0057-F Final Rule signals a clear move toward electronic prior authorization through Fast Healthcare Interoperability Resources-based application programming interfaces and standardized data exchange.7 Federal momentum on PA reform has been building across multiple congressional sessions.
But policy change takes time. Independent pharmacies are navigating today's system with today's tools. Closing the information gap does not require a legislative fix first. It requires the same muscle pharmacists have already built around every other Medicare and payer transition: catch the friction before it becomes an abandoned prescription, one documented payer requirement at a time.
About the Author
Mohammed Chammout, PharmD, BCMTMS, is a Clinical Access and Reimbursement Specialist at Outcomes in Dearborn, Michigan, with experience in clinical coverage strategy, specialty pharmacy management, and prior authorization optimization. His practice focus includes medication access barriers and payer policy across primary care and specialty settings.
REFERENCES
Syed S, Lin JK, Chino F. Modern landscape of prior authorization burden at a specialty cancer pharmacy. JCO Onc Pract. 2025;21(10_suppl):177. doi:10.1200/OP.2025.21.10_suppl.177
Healthcare professionals highlight medication prior authorization challenges & solutions. Surescripts. May 2026. Accessed August 13, 2026. https://surescripts.com/prior-authorization-challenges-data